Skip to main navigation Skip to search Skip to main content

Molecular abnormalities and clinical features in adult patients with acute myeloid leukemia in Thailand

  • Ramathibodi Hospital

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Background: The genetic heterogeneity observed in acute myeloid leukemia (AML) contributes to a wide range of clinical presentations and prognoses. We conducted a retrospective study to investigate genetic abnormalities, clinical characteristics, and survival of AML patients. Methods: Targeted exome analysis of 25 genes using a QIAact Myeloid DNA UMI Panel with the GeneReader NGS was performed. Results: De novo AML (dAML) and secondary AML (sAML) were observed in 163 and 56 patients, respectively. ASXL1, SRSF2, and RUNX1 mutations were significantly observed in sAML patients. Among dAML patients, mutant IDH1, ASXL1, TP53, and TET2 were associated with low WBC count (< 4 × 109/L), and mutations of FLT3-ITD and NPM1 were associated with high WBC count (> 100 × 109/L). In dAML group, KIT and FLT3-TKD mutations were commonly found in favorable cytogenetic risk, RAS and SF3B1 mutations were significantly observed in the abnormal chromosome 3 group, whereas IDH1, IDH2, RUNX1, and SRSF2 mutations were significantly observed in trisomy group. Mutant TP53 was seen significantly in AML patients with complex and monosomy karyotypes. ASXL1, IDH1, IDH2, TP53, and SRSF2 mutations were independent factors associated with poor OS through univariate analysis. Nevertheless, multivariate analysis showed IDH1 (HR = 2.699; 95% CI: 1.331–5.473), TP53 (HR = 2.200; 95% CI: 1.409–3.435) and ASXL1 (HR = 1.592; 95% CI: 1.040–2.436) mutations were significantly associated with short OS in AML patients. In contrast, RUNX1 (HR = 3.667; 95% CI: 1.213–11.084) and DNMT3A (HR = 2.094; 95% CI: 1.080–4.081) mutations were significantly associated with poor DFS on multivariate analysis. Conclusions: The complexity of AML was influenced by various cytogenetic and molecular abnormalities, which contributed to patients’ heterogeneous presentation and survival outcomes. In addition to the previous data, IDH1, IDH2, and DNMT3A mutations might have affected survival outcomes in AML patients in our retrospective cohort. However, further studies with larger sample sizes are needed to validate these observations.

Original languageEnglish
Article number128
JournalDiagnostic Pathology
Volume20
Issue number1
DOIs
Publication statusPublished - Dec 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute myeloid leukemia
  • Clinical features
  • Cytogenesis
  • Molecular abnormality

Fingerprint

Dive into the research topics of 'Molecular abnormalities and clinical features in adult patients with acute myeloid leukemia in Thailand'. Together they form a unique fingerprint.

Cite this